Some patients' cancer returns after a successful course of treatment. This is called a relapse.
Some patients' cancer does not respond to treatment. This is called refractory chronic myelomonocytic leukemia (CMML).
If you have relapsed or refractory CMML, talk with your doctor about whether taking part in a clinical trial may be a good option for you.
- Download or order The Leukemia & Lymphoma Society's free booklet, Chronic Myelomonocytic Leukemia (CMML) and Juvenile Myelomonocytic Leukemia (JMML)